肺通气功能障碍对冠心病患者预后的影响:单中心观察研究

IF 1.9 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Reviews in cardiovascular medicine Pub Date : 2024-05-29 eCollection Date: 2024-06-01 DOI:10.31083/j.rcm2506197
Yu-Shan Li, Qiang Ren, Jian Zhang, Yan-Chun Liang, Ya-Ling Han, Quan-Yu Zhang
{"title":"肺通气功能障碍对冠心病患者预后的影响:单中心观察研究","authors":"Yu-Shan Li, Qiang Ren, Jian Zhang, Yan-Chun Liang, Ya-Ling Han, Quan-Yu Zhang","doi":"10.31083/j.rcm2506197","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with coronary artery disease (CAD) often experience pulmonary ventilation dysfunction following their initial event. However, there is insufficient research exploring the relationship between this dysfunction and CAD prognosis.</p><p><strong>Methods: </strong>To address this gap, a retrospective observational study was conducted involving 3800 CAD patients without prior pulmonary ventilation disease who underwent cardiopulmonary exercise testing (CPET) during hospitalization between November 2015 and September 2021. The primary endpoint was a composite of major adverse cardiovascular events (MACE), such as death, myocardial infarction (MI), repeat revascularization, and stroke. Propensity score matching (PSM) was used to minimize selection bias between the two groups, with a subgroup analysis stratified by smoking status.</p><p><strong>Results: </strong>The results showed that patients were divided into normal (n = 2159) and abnormal (n = 1641) groups based on their pulmonary ventilation function detected by CPET, with 1469 smokers and 2331 non-smokers. The median follow-up duration was 1237 (25-75% interquartile range 695-1596) days. The primary endpoint occurred in 390 patients (10.26%). 1472 patients in each of the two groups were enrolled in the current analysis after PSM, respectively. However, pulmonary function was not associated with MACE before (hazard ratio (HR) 1.20, 95% confidence interval (95% CI) 0.99-1.47; Log-rank <i>p</i> = 0.069) or after PSM (HR 1.07, 95% CI 0.86-1.34; Log-rank <i>p</i> = 0.545) among the entire population. Nonetheless, pulmonary ventilation dysfunction was significantly associated with an increased risk of MACE in smoking patients (HR 1.65, 95% CI 1.25-2.18; <i>p</i> <math><mo><</mo></math> 0.001) but not in non-smoking patients (HR 0.81, 95% CI 0.60-1.09; <i>p</i> = 0.159). In addition, there was a significant interaction between current smoking status and pulmonary ventilation dysfunction on MACE (<i>p</i> for interaction <math><mo><</mo></math> 0.001).</p><p><strong>Conclusions: </strong>Pulmonary ventilation dysfunction identified through CPET was independently associated with long-term poor prognosis in smoking patients with CAD but not in the overall population.</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11270079/pdf/","citationCount":"0","resultStr":"{\"title\":\"Impact of Pulmonary Ventilation Dysfunction on Prognosis of Patients with Coronary Artery Disease: A Single-Center, Observational Study.\",\"authors\":\"Yu-Shan Li, Qiang Ren, Jian Zhang, Yan-Chun Liang, Ya-Ling Han, Quan-Yu Zhang\",\"doi\":\"10.31083/j.rcm2506197\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Patients with coronary artery disease (CAD) often experience pulmonary ventilation dysfunction following their initial event. However, there is insufficient research exploring the relationship between this dysfunction and CAD prognosis.</p><p><strong>Methods: </strong>To address this gap, a retrospective observational study was conducted involving 3800 CAD patients without prior pulmonary ventilation disease who underwent cardiopulmonary exercise testing (CPET) during hospitalization between November 2015 and September 2021. The primary endpoint was a composite of major adverse cardiovascular events (MACE), such as death, myocardial infarction (MI), repeat revascularization, and stroke. Propensity score matching (PSM) was used to minimize selection bias between the two groups, with a subgroup analysis stratified by smoking status.</p><p><strong>Results: </strong>The results showed that patients were divided into normal (n = 2159) and abnormal (n = 1641) groups based on their pulmonary ventilation function detected by CPET, with 1469 smokers and 2331 non-smokers. The median follow-up duration was 1237 (25-75% interquartile range 695-1596) days. The primary endpoint occurred in 390 patients (10.26%). 1472 patients in each of the two groups were enrolled in the current analysis after PSM, respectively. However, pulmonary function was not associated with MACE before (hazard ratio (HR) 1.20, 95% confidence interval (95% CI) 0.99-1.47; Log-rank <i>p</i> = 0.069) or after PSM (HR 1.07, 95% CI 0.86-1.34; Log-rank <i>p</i> = 0.545) among the entire population. Nonetheless, pulmonary ventilation dysfunction was significantly associated with an increased risk of MACE in smoking patients (HR 1.65, 95% CI 1.25-2.18; <i>p</i> <math><mo><</mo></math> 0.001) but not in non-smoking patients (HR 0.81, 95% CI 0.60-1.09; <i>p</i> = 0.159). In addition, there was a significant interaction between current smoking status and pulmonary ventilation dysfunction on MACE (<i>p</i> for interaction <math><mo><</mo></math> 0.001).</p><p><strong>Conclusions: </strong>Pulmonary ventilation dysfunction identified through CPET was independently associated with long-term poor prognosis in smoking patients with CAD but not in the overall population.</p>\",\"PeriodicalId\":20989,\"journal\":{\"name\":\"Reviews in cardiovascular medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11270079/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reviews in cardiovascular medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.31083/j.rcm2506197\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/6/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in cardiovascular medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.31083/j.rcm2506197","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景:冠状动脉疾病(CAD)患者在初次发病后往往会出现肺通气功能障碍。然而,有关这种功能障碍与 CAD 预后之间关系的研究却不足:为了填补这一空白,研究人员开展了一项回顾性观察研究,研究对象包括 2015 年 11 月至 2021 年 9 月期间住院期间接受心肺运动测试(CPET)的 3800 名无肺通气疾病的 CAD 患者。主要终点是主要不良心血管事件(MACE)的复合指标,如死亡、心肌梗死(MI)、再次血管重建和中风。研究采用倾向评分匹配法(PSM)最大限度地减少了两组患者的选择偏差,并根据吸烟状况进行了亚组分析:结果显示,根据 CPET 检测到的肺通气功能,将患者分为正常组(n = 2159)和异常组(n = 1641),其中吸烟者 1469 人,非吸烟者 2331 人。中位随访时间为 1237 天(25%-75% 四分位间范围为 695-1596 天)。390名患者(10.26%)达到了主要终点。在 PSM 后,两组各有 1472 名患者被纳入本次分析。然而,在整个人群中,肺功能与 PSM 前(危险比 (HR) 1.20,95% 置信区间 (95% CI) 0.99-1.47;Log-rank p = 0.069)或 PSM 后(HR 1.07,95% CI 0.86-1.34;Log-rank p = 0.545)的 MACE 无关。然而,肺通气功能障碍与吸烟患者的 MACE 风险增加显著相关(HR 1.65,95% CI 1.25-2.18;P 0.001),但与非吸烟患者无关(HR 0.81,95% CI 0.60-1.09;P = 0.159)。此外,当前吸烟状况与肺通气功能障碍对MACE的影响存在明显的交互作用(交互作用的P值为0.001):结论:在吸烟的 CAD 患者中,通过 CPET 发现的肺通气功能障碍与长期不良预后有独立关联,而在总体人群中则没有关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impact of Pulmonary Ventilation Dysfunction on Prognosis of Patients with Coronary Artery Disease: A Single-Center, Observational Study.

Background: Patients with coronary artery disease (CAD) often experience pulmonary ventilation dysfunction following their initial event. However, there is insufficient research exploring the relationship between this dysfunction and CAD prognosis.

Methods: To address this gap, a retrospective observational study was conducted involving 3800 CAD patients without prior pulmonary ventilation disease who underwent cardiopulmonary exercise testing (CPET) during hospitalization between November 2015 and September 2021. The primary endpoint was a composite of major adverse cardiovascular events (MACE), such as death, myocardial infarction (MI), repeat revascularization, and stroke. Propensity score matching (PSM) was used to minimize selection bias between the two groups, with a subgroup analysis stratified by smoking status.

Results: The results showed that patients were divided into normal (n = 2159) and abnormal (n = 1641) groups based on their pulmonary ventilation function detected by CPET, with 1469 smokers and 2331 non-smokers. The median follow-up duration was 1237 (25-75% interquartile range 695-1596) days. The primary endpoint occurred in 390 patients (10.26%). 1472 patients in each of the two groups were enrolled in the current analysis after PSM, respectively. However, pulmonary function was not associated with MACE before (hazard ratio (HR) 1.20, 95% confidence interval (95% CI) 0.99-1.47; Log-rank p = 0.069) or after PSM (HR 1.07, 95% CI 0.86-1.34; Log-rank p = 0.545) among the entire population. Nonetheless, pulmonary ventilation dysfunction was significantly associated with an increased risk of MACE in smoking patients (HR 1.65, 95% CI 1.25-2.18; p < 0.001) but not in non-smoking patients (HR 0.81, 95% CI 0.60-1.09; p = 0.159). In addition, there was a significant interaction between current smoking status and pulmonary ventilation dysfunction on MACE (p for interaction < 0.001).

Conclusions: Pulmonary ventilation dysfunction identified through CPET was independently associated with long-term poor prognosis in smoking patients with CAD but not in the overall population.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Reviews in cardiovascular medicine
Reviews in cardiovascular medicine 医学-心血管系统
CiteScore
2.70
自引率
3.70%
发文量
377
审稿时长
1 months
期刊介绍: RCM is an international, peer-reviewed, open access journal. RCM publishes research articles, review papers and short communications on cardiovascular medicine as well as research on cardiovascular disease. We aim to provide a forum for publishing papers which explore the pathogenesis and promote the progression of cardiac and vascular diseases. We also seek to establish an interdisciplinary platform, focusing on translational issues, to facilitate the advancement of research, clinical treatment and diagnostic procedures. Heart surgery, cardiovascular imaging, risk factors and various clinical cardiac & vascular research will be considered.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信